Journal
NEUROGASTROENTEROLOGY AND MOTILITY
Volume 26, Issue 12, Pages 1669-1676Publisher
WILEY
DOI: 10.1111/nmo.12475
Keywords
biomarkers; IBS; positive diagnosis; treatment effect
Ask authors/readers for more resources
Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder which represents a major cost to health-care services. The diagnosis of IBS is currently performed by means of symptom-based diagnostic criteria, but there has been an ongoing interest in developing biomarkers which could simplify the diagnosis and/or evaluating the effect of treatments. This article reviews the current literature concerning the proposed biomarkers including those of altered gut motility, of visceral hypersensitivity, of abnormal brain mechanisms, of serum, fecal and mucosal inflammation and of increased intestinal permeability.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available